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Background: This report describes emergency response following an imported vaccine derived poliovirus (VDPV)
case from Myanmar to Yunnan Province, China and the cross-border collaboration between China and Myanmar.
Immediately after confirmation of the VDPV case, China disseminated related information to Myanmar with the
assistance of the World Health Organization.
Methods: A series of epidemiological investigations were conducted, both in China and Myanmar, including
retrospective searches of acute flaccid paralysis (AFP) cases, oral poliovirus vaccine (OPV) coverage assessment, and
investigation of contacts and healthy children.
Results: All children <2 years of age had not been vaccinated in the village where the VDPV case had lived in the
past 2 years. Moreover, most areas were not covered for routine immunization in this township due to vaccine
shortages and lack of operational funds for the past 2 years.
Conclusions: Cross-border collaboration may have prevented a potential outbreak of VDPV in Myanmar. It is
necessary to reinforce cross-border collaboration with neighboring countries in order to maximize the leverage of
limited resources.
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Since 2012, circulation of indigenous wild poliovirus
(WPV) has been confined to three countries: Afghanistan,
Nigeria, and Pakistan [1]. Despite significant achievements
since the launch of the Global Polio Eradication Initiative
in 1988, many previously polio-free countries remain at
risk for the disease and have been affected by WPV im-
portation from remaining endemic countries [2-5]. With
increasing globalization, population mobility is contribut-
ing to the transmission of infectious diseases between
countries, as cross-border population movement impedes
efforts to prevent transmission of infectious diseases. For* Correspondence: ynepidzr@sohu.com; Hmluo@vip.sina.com
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unless otherwise stated.example, in 2009, 98.8% of total malaria cases in Yunnan
Province, China were found to be imported from neigh-
boring countries [6].
In China, the last indigenous case of WPV was re-
ported in September 1994 [7]. China and the other
countries of the Western Pacific Region were declared
polio-free in October 2000 [8]. However, national health
departments in China must remain vigilant regarding
the risk of WPV importation from bordering endemic
countries. Instances of WPV importation were detected
in China before the region was declared polio-free: in
1995 and 1996 in Yunnan Province [9], and in 1999 in
Qinghai province [10,11]. Moreover, after being polio-
free for more than 10 years, on August 25, 2011, an out-
break was confirmed in Xinjiang Uygur Autonomous
Region, China following importation of type 1 WPV
originated from neighboring Pakistan [12-14].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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period of 2000-2005, but a single case of type 1 vaccine
derived poliovirus (VDPV) was reported in April 2006.
After several years without WPV cases, an outbreak of
11 type 1 WPV cases occurred in Myanmar in 2007,
which was confirmed as the re-introduction of WPV,
with the last reported paralyzed case in May 2007 [15].
Subsequently, an additional four type 1 VDPV cases
were reported in 2007, and a type 1 VDPV case was re-
ported in December 2010.
The Global Polio Eradication Initiative of World
Health Organization (WHO) recommends reporting and
laboratory testing of fecal specimens for all cases of
acute flaccid paralysis (AFP) among children < 15 years
of age and suspected poliomyelitis in a person of any age
as the standard means of WPV and VDPV surveillance.
The Chinese government initiated AFP surveillance in
several provinces, following WHO guidelines in 1991. In
1993, surveillance was extended to the national level
conducted by the Chinese Center for Disease Control
and Prevention (China CDC) under the leadership of
Ministry of Health (MoH). WHO established a global
polio laboratory network, which includes a Polio Re-
gional Reference Laboratory in China, to confirm polio-
virus infections.
This report describes the cross-border collaboration
between China and Myanmar on the public health re-
sponse of an importation of VDPV case that occurred in
Yunnan Province, China, in June 2012; the last reported
case of WPV infection in Yunnan, China was imported
from Myanmar in 1996 [9]. This cross-border collabor-
ation and public health response is a model example for
other countries which have borders with WPV endemic
countries, and the lessons learned may be incorporated




Yunnan Province is situated in southwest China, with an
area of 394,000 km2. Yunnan shares 4,060 kilometers of
international borders with Myanmar in the west and
southwest and with Vietnam and Laos in the south. Six
of 16 prefectures in Yunnan are adjacent with Myanmar,
with nearly 2,000 kilometers of international borders.
Moreover, there are few natural barriers between the two
countries, and the border habitants of each country inter-
act very frequently. In 2011 the population of Yunnan
Province was estimated to be 46.3 million with 9.5 million
children younger than 15 years of age; the average popula-
tion density is 118 persons/km2, and the annual birth rate
is approximately 12.7‰.
The VDPV case lived in a Village (Village A, Township
B) which is a part of North Shan State in Myanmar withan estimated 73,000 population. Township B is under
the leadership of Kokang Special Administrative Region
bordering with Yunnan Province. Many parts of the
township are geographically hard to reach and are un-
able to be accessed in the rainy season. The township
has a 50-bed hospital in an urban area and one 16-bed
station hospital in a sub-township. Medical treatment
and public health services are provided by township
health staff.
Case ascertainment and VDPV case definition
Cases with paralytic polio were identified through an
AFP surveillance system. CDC staff at the county-level
routinely investigate AFP cases reported by health care
centers and hospitals, collect stool specimens and assess
residual paralysis 60 days after the onset of paralysis.
Clinical and epidemiological information on AFP cases
are abstracted from medical records and/or obtained
from case investigations; a standard case investigation
form is used in China.
In accordance with WHO current recommendations, a
VDPV case was defined as an AFP case from whom
Sabin-related poliovirus (type 2 with ≥6 nt VP1 substitu-
tions; type1 and 3 with ≥10 nt VP1 substitutions) was
isolated from ≥1 stool specimen without WPV isolated,
and who was determined to be polio-compatible by a
provincial Polio Expert Committee after the standard
60-days follow-up examination.
Retrospective searching of AFP cases
Records of all county- and prefecture-level hospitals in
Lincang City, Yunnan Province where the VDPV case
sought health care were reviewed for additional AFP
cases. In Myanmar, retrospective searches for AFP cases
were conducted in hospitals in township B and through
a house-to-house search in the affected village and
neighboring areas. The definition of AFP case was AFP
case <15 years old, or suspected polio case at any age,
paralyzed between January 1, 2010 and the survey date.
Oral poliovirus vaccine (OPV) coverage assessment
To determine immunization coverage, convenience surveys
were conducted in four counties (two counties the case
visited and two counties bordering Myanmar) in Yunnan
Province. Quick assessment of OPV coverage was con-
ducted and performance of routine immunization were also
evaluated in Township B.
Investigation of contacts and healthy children
Stool specimens were collected from hospital contacts of
the VDPV case and healthy children <5 years of age in the
two counties (Zhenkang County and Linxiang County)
that the VDPV case visited in Lincang City, Yunnan
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from close contacts of the VDPV case.
Isolation and characterization of poliovirus isolates
Stool specimens were forwarded to the provincial polio
laboratory where viral isolation was performed on L20B
and RD cell cultures and viral isolates were identified by
micro-neutralization assay. Poliovirus isolates were for-
warded to the National Polio Laboratory where intraty-
pic differentiation was performed by polymerase chain
reaction–restriction fragment–length polymorphism and
by enzyme-linked immunosorbent assay. The full VP1
genomic region of poliovirus isolates was sequenced
with an ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction kit and an automated DNA sequencer.
Sequence data were compared with those of reference
strains (GenBank accession no. AY184219). All contact
specimens collected in Myanmar were sent to WHO
accredited National Health Laboratory Yangon for polio-
virus testing.
Ethical considerations
This study was approved by the Chinese Center for
Disease Control and Prevention institutional review
board. Written informed consent regarding anonymizing
publication of VDPV infection was provided by guardian
of the index case in Myanmar and the guardians of four
AFP cases in Lincang city of Yunnan Province, after
study staff explained fully to guardian about the purpose
of the study, and the risks and benefits of anonymizing
publication.
Statistical analysis
Statistical tests were performed using SAS 9.1 software
(SAS Institute Inc, Cary, NC, USA). A p-value of <0.05




The case, 18 months old, lived in a Village of Township
B, North Shan State in Myanmar. The child had no pre-
vious history of OPV vaccination, no history of travelling
outside the village 4-6 weeks prior to illness, or any fam-
ily visits. In the first instance, the child developed high
fever; two days later, the child was brought to a local
clinic, where an intramuscular injection (drug was un-
known) was given on his left buttock; fever subsided
after injection, but the child developed bilateral weak-
ness of the lower limbs on the same night; the weakness
worsened by next day and the child was unable to stand
or walk.
Four days later, the child went to a Hospital in Township
B and was referred to a hospital in Zhenkang County (inChina) where he was then referred to a Hospital in Lin-
cang City and was reported as an AFP case. Type 1 VDPV
strains were isolated from both stool specimens collected
6 and 7 days after the onset of AFP, with 21 (2.3%) nt
VP1 substitutions from Sabin poliovirus. After staying in
Lincang City for more than one week, the child returned
to Myanmar because of no improvement in symptoms.
Therefore, no additional stool sample was collected and
VDPV excretion was not followed up for the case. No
medical test for immunodeficiency was done without final
classification of VDPV.
Cross-border collaboration between China and Myanmar—
information sharing
Immediately after confirmation of the VDPV case, China
CDC informed WHO about the VDPV case and required
the assistance of WHO for sharing related information
with Myanmar. The government of Myanmar received
the report about the VDPV importation with the help of
the WHO country office in China, WHO Western Pa-
cific Regional Office, WHO Regional Office for South-
East Asia, and WHO country office in Myanmar.
Based on the information provided by the Chinese MoH,
Myanmar’s MoH, and the WHO country office in
Myanmar, the VDPV case was located and additional de-
tailed epidemiological information was collected on the
outbreak and immunization activities were conducted in-
cluding OPV coverage assessment, AFP case searching and
specimen collection among close contacts and healthy chil-
dren by a joint team consisting of officials from Myanmar’s
MoH and WHO country office in Myanmar. China,
WHO, and Myanmar maintained communication regard-
ing the epidemiology of the outbreak and emergency re-
sponse activities.
Investigation of contacts and healthy children
In Yunnan Province, stool specimens were collected from
two hospital contacts who stayed in the same room in the
hospital of Lincang City, with negative results for both
poliovirus and non-polio enterovirus (NPEV). In Linxiang
and Zhenkang counties, stool specimens were also collected
from 50 healthy children <5 years of age in an area with a
concentrated migrant population, all of which were negative
for poliovirus except 8 (16%) specimens positive for NPEV.
In Myanmar, stool specimens were collected from 10
close contacts including family and those who encoun-
tered the VDPV case in the hospital after paralysis (4 in
the Village where the case lived, 1 in another Village
where the case had stayed and 5 in Township Hospital),
with negative results for both poliovirus and NPEV.
OPV coverage assessment and routine immunization
Convenience surveys for OPV coverage were conducted
in 4 counties of Lincang City: Linxiang and Zhenkang
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(Gengma and Cangyuan) which border Myanmar. A
total of 365 children were enrolled: 65 < 1 year of age
and 300 ≥ 1 year of age (Table 1). Among the 365 sub-
jects enrolled, 356 (97.5%) had a vaccination certificate
and 363 (99.5%) had received at least one dose of
OPV. Among 300 participants ≥1 year of age, 279 (93.0)
had received more than 3 doses of OPV (OPV3). OPV3
rates by county were also high among subjects ≥1 year
of age, with the lowest rate (86.3%) in market place of
Linxiang County.
The VDPV case had a three month old sibling who had
also not received any vaccinations. The township medical
officer reported that there had been no vaccination con-
ducted since last 2 years in this village, and that most villages
did not have adequate access to vaccination in Township
B. Moreover, most areas were not covered for routine
immunization in this township due to vaccine shortages
and lack of operational funds in the past 2 years. The re-
ported OPV3 coverage among children <1 year of age were
48% in 2009, 63% in 2010, and 73% in 2011, respectively.
Retrospective searching of AFP cases
Medical records for both inpatients and outpatients were









Yes No Rate (
Linxiang Market Place
2-12 18 18 0 100.0
>12 80 80 0 100.0
Zhenkang
Market Place
2-12 5 4 1 80.0
>12 25 24 1 96.0
Mengpeng Township
2-12 6 6 0 100.0
>12 27 26 1 96.3
Mengdui Township
2-12 6 6 0 100.0
>12 24 24 0 100.0
Cangyuan
Market Place
2-12 12 10 2 83.3
>12 49 46 3 93.9
Mengjiao Town
2-12 4 4 0 100.0
>12 26 26 0 100.0
Gengma
Market Place
2-12 6 6 0 100.0
>12 23 23 0 100.0
Hepai Town
2-12 1 1 0 100.0
>12 28 28 0 100.0
Mengding Town
2-12 7 6 1 85.7
>12 18 18 0 100.0
Total
2-12 65 61 4 93.8
>12 300 295 5 98.3the 4 aforementioned counties of Lincang City. A total
of 4 AFP cases were found: 2 cases in Linxiang County,
one in Zhenkang County, and one in Cangyuan County;
all of these cases had been reported.
In Myanmar, no additional AFP cases were found during
active case searches in Township B Hospital nor during
house-to-house searches in the Village and neighboring
areas.
AFP surveillance performance
The overall annualized incidence of non-polio AFP
(NPAFP) was 2.98 per 100,000 children < 15 years of age
in Yunnan Province from January to May 2012, and
NPAFP rates were >1/100,000 in almost all prefectures
except for Xishuangbanna Prefecture and Nujiang City
where no NPAFP cases were reported (Table 2). In 2011,
with the exception of Xishuangbanna Prefecture, NPAFP
rates were higher than 1 case per 100,000 children in all
prefectures. Another important indicator, adequate stool
specimen collection rate, was also met in almost all
prefectures.
In Township B Hospital, doctors and health workers
had fairly good knowledge on AFP surveillance. An AFP
poster for awareness purpose, including almost all the








Rate (%)%) 0 1 2 ≥3 Unknown
0 3 1 14 0 100.0 77.8
0 3 8 69 0 100.0 86.3
1 1 1 2 0 80.0 40.0
0 0 1 24 0 100.0 96.0
0 1 2 3 0 100.0 50.0
0 0 3 24 0 100.0 88.9
0 3 0 3 0 100.0 50.0
0 0 0 24 0 100.0 100.0
0 1 1 10 0 100.0 83.3
0 1 0 48 0 100.0 98.0
1 0 0 3 0 75.0 75.0
0 1 0 25 0 100.0 96.2
0 0 0 6 0 100.0 100.0
0 1 1 21 0 100.0 91.3
0 0 0 1 0 100.0 100.0
0 0 0 28 0 100.0 100.0
0 2 2 3 0 100.0 42.9
0 1 1 16 0 100.0 88.9
2 11 7 45 0 96.9 69.2
0 7 14 279 0 100.0 93.0
Table 2 Main performance indicators of AFP surveillance among children <15 years of age by prefecture in Yunnan
























Kunming City 22 1.71 100.0 81.8 72.7 100.0 100.0
Qujing City 21 1.54 95.2 90.5 90.5 100.0 100.0
Yuxi City 31 6.53 96.8 96.8 96.8 100.0 100.0
Baoshan City 20 3.69 100.0 90.0 90.0 100.0 100.0
Zhaotong City 22 1.84 90.9 95.5 90.9 90.9 100.0
Chuxiong
Prefecture
22 3.93 100.0 100.0 100.0 100.0 100.0
Honghe
Prefecture
20 2.08 100.0 85.0 85.0 100.0 95.0
Wenshan
Prefecture
19 2.28 100.0 89.5 84.2 88.9 100.0
Pu’er City 16 2.86 100.0 93.8 93.8 100.0 100.0
Xishuangbanna
Prefecture
2 0.87 100.0 50.0 50.0 100.0 100.0
Dali Prefecture 18 2.35 94.4 100.0 100.0 100.0 100.0
Dehong
Prefecture
17 6.40 100.0 100.0 100.0 100.0 100.0
Lijiang City 12 4.52 100.0 83.3 83.3 100.0 100.0
Nujiang City 4 3.38 100.0 50.0 50.0 100.0 100.0
Diqing City 1 1.19 100.0 100.0 100 100.0 100.0
Lincang City 13 2.32 100.0 92.3 92.3 92.3 100.0
Yunnan Province 260 2.58 98.1 91.5 90.0 98.1 99.6
2012 (January
to May)
Kunming City 20 4.89 100.0 95.0 95.0 100.0 100.0
Qujing City 8 1.41 100.0 75.0 75.0 100.0 100.0
Yuxi City 4 2.27 100.0 100.0 100.0 100.0 100.0
Baoshan City 4 1.89 100.0 100.0 100.0 100.0 100.0
Zhaotong City 14 2.44 100.0 92.9 92.9 78.6 100.0
Chuxiong
Prefecture
7 3.59 100.0 100.0 100.0 100.0 100.0
Honghe
Prefecture
10 2.51 100.0 100.0 100.0 100.0 100.0
Wenshan
Prefecture
5 1.44 100.0 100.0 100.0 100.0 100.0
Pu’er City 7 3.60 100.0 85.7 85.7 71.4 100.0
Xishuangbanna
Prefecture
0 0.0 − − − − −
Dali Prefecture 9 3.23 100.0 100.0 100.0 100.0 100.0
Dehong
Prefecture
11 10.49 100.0 100.0 100.0 90.9 100.0
Lijiang City 8 8.58 100.0 100.0 100.0 100.0 100.0
Nujiang City 0 0.0 − − − − −
Diqing City 1 3.30 100.0 100.0 100.0 100.0 100.0
Lincang City 9 4.38 100.0 100.0 100.0 100.0 100.0
Yunnan Province 117 2.98 100.0 95.7 95.7 94.9 100.0
§Annualized NPAFP incidence in 2012 (January to May), No. of AFP Cases × 12/5 × 100, 000/100, 000)/ No. of children <15 years of age.
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clinics in Township B, which were not part of the AFP
surveillance system. AFP cases were not reported in
Township B and neighboring townships, and the sensi-
tivity indicator (>1 case per 100,000 children <15 years
of age) of AFP surveillance was not met.
Supplementary immunization activities (SIAs)
OPV catch-ups were conducted among children <6 years
of age in Lincang City, Yunnan Province. The targeted
children also included those from Myanmar who attend
school, travel or live in Lincang City. OPV catch-ups in
Yunnan Province and SIAs in Myanmar were conducted
at similar time.
In order to control the outbreak timely and effectively,
outbreak response immunization was conducted in a
month after paralysis onset of the VDPV case in 6 neigh-
boring villages, including one urban border crossing
ward of Township B. Six hundred fifty children were
given one dose of trivalent OPV. In addition, two
months later, two rounds of house-to-house supplemen-
tary immunization activities (SIAs) were conducted in
19 townships of North Shan State in Myanmar, covering
233,000 children <6 years of age.
Discussion
Based on clinical examination the index child was diag-
nosed as clinically compatible with polio, and type 1
VDPV (21 nucleotides substitution) was isolated from
stool specimens, so the child was classified as a VDPV
case. This is the first report of an imported VDPV case in
China, although WPV importation had been detected by
AFP surveillance in the past. The Chinese MOH immedi-
ately disseminated related epidemiological information to
Myanmar upon detection of the VDPV case with assist-
ance from WHO. Based on information provided by
the Chinese MoH, a timely emergency response was con-
ducted in Myanmar, including an epidemiological investi-
gation and SIAs. China and Myanmar maintained
communication, regularly updating each other on investi-
gation activities. This effort should be a model example of
cross-border collaboration for global polio eradication.
High quality of routine immunization against polio
and AFP surveillance are two key elements for polio
eradication. Low immunization immunity due to poor
OPV coverage in routine immunization was the major
risk factor related with VDPV outbreak. The township
medical officer reported that most areas were not cov-
ered for routine immunization in this township in
the past 2 years. The reported OPV3 coverage among
children <1 year of age were 48% in 2009, 63% in 2010,
and 73% in 2011, respectively. Moreover, AFP Surveil-
lance system was found to be inadequate in the area of
the VDPV case. Therefore, retrospective searching ofAFP cases was necessary for identifying under-reported
AFP cases during field investigation.
Imported WPV and VDPV cases were detected timely
by AFP surveillance system in Yunnan Province, which
was based on the performance of AFP surveillance. More-
over, high population immunity had prevented transmis-
sion of poliovirus without subsequent outbreaks, although
importation has occurred many times. The quick assess-
ment of OPV coverage showed that the immunization rate
was high in Lincang City, with 93.0% of children >1 year
of age fully immunized. A serologic study conducted to es-
timate poliovirus antibody seroprevalence in 2010, indi-
cated that more than 85% of children were seropositive
for poliovirus serotype 1 in Lincang City [16]. The risk
of cVDPV outbreak was considered to be low according
to risk assessment, so OPV catch-up other than SIAs
was conducted. It is necessary to strengthen routine
immunization and AFP surveillance further until WPV is
eradicated worldwide.
OPV is recommended by national immunization pro-
gram in both China and Myanmar. However, due to a high
liability of genetic mutation and recombination with other
enteroviruses [17], one disadvantage associated with OPV
is the rare occurrence of VDPVs. The cVDPV in Nigeria
have indicated the potential risk of prolonged transmission
of the vaccine virus among population with non-optimal
immunity [18]. The goal of polio eradication is to complete
eradication and containment of all wild, vaccine-related
and Sabin polioviruses. Until WPV can be eliminated then
programs utilizing OPV must be continued which entails
an ongoing risk of VDPV outbreaks. Hence efforts to elim-
inate WPV must continue, and all countries must maintain
effective immunization and AFP surveillance programs.
Timely information sharing between China and Myanmar
may have avoided a potential outbreak of circulated VDPV
(cVDPV) in Myanmar, considering the immunity gap
among children in this high risk area where the VDPV
case lived. The success in collaboration and the potential
benefits attained emphasize the need to strengthen cross-
border collaborative efforts among countries that neighbor
endemic countries. It is noteworthy that increasing efforts
are taken for cross-border collaboration in recent years.
Intense cross-border migration continues in both direc-
tions, favoring continuous virus transmission between
Afghan and Pakistan [19]. Therefore, synchronized cross-
border polio campaigns were conducted in these two
countries, ensuring simultaneous and comprehensive
coverage of children in transit through the border areas
[20]. In addition, many of cross-border meetings were held
to explore a formalized approach to collaboration [21,22].
However, it took over 7 days for Myanmar to receive
the information on the VDPV case, which was due to
many counterparts involved in the information delivery
in addition to the countries of China and Myanmar,
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WHO Western Pacific Regional Office, WHO Regional
Office for South-East Asia and WHO country office in
Myanmar. To promote further efficient communication,
working mechanisms for information exchange and
emergency response collaboration should be developed
between China and Myanmar. Historically, to control
WPV importation from Myanmar, China and Myanmar
simultaneously conducted OPV SIAs in the border areas
of Yunnan Province, China and Shan and Kachin States,
Myanmar. Due to good collaboration, a WPV outbreak
did not take place in Yunnan Province, although imported
WPV cases were monitored [9]. Cross-border collabor-
ation with neighboring countries is particularly important
for China, as it shares a border with two endemic coun-
tries (Afghanistan and Pakistan). However, a formalized
collaboration approach is lacking. Based on the previous
experience collaborating with Myanmar, the following
mechanisms should be considered:
 A list of key contacts should be developed, who are
responsible for polio-related issues on each side of
the border;
 AFP surveillance and coverage data should be
shared regularly;
 Each country should immediately inform the other
upon detecting WPV cases, VDPV cases or a cluster
of AFP cases in border townships or counties;
 Cross-border meetings should be conducted
regularly to better understand each other public
health system;
 Personnel and resources should be shared, including
technical guidance; and
 SIAs should be synchronized if a WPV outbreak is
detected.
Conclusion
The collaboration between China and Myanmar may have
prevented a potential cVDPV outbreak in Myanmar. Con-
sidering China shares borders with two endemic countries,
it is necessary to reinforce cross-border collaboration with
neighboring countries, which can maximize the leverage
of limited resources. Conducting high quality routine
immunization and AFP surveillance should be maintained
until WPV is eradicated worldwide.
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